Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Biol Chem ; 287(18): 14545-56, 2012 Apr 27.
Artigo em Inglês | MEDLINE | ID: mdl-22383523

RESUMO

TWINKLE is a nucleus-encoded human mitochondrial (mt)DNA helicase. Point mutations in TWINKLE are associated with heritable neuromuscular diseases characterized by deletions in the mtDNA. To understand the biochemical basis of these diseases, it is important to define the roles of TWINKLE in mtDNA metabolism by studying its enzymatic activities. To this end, we purified native TWINKLE from Escherichia coli. The recombinant TWINKLE assembles into hexamers and higher oligomers, and addition of MgUTP stabilizes hexamers over higher oligomers. Probing into the DNA unwinding activity, we discovered that the efficiency of unwinding is greatly enhanced in the presence of a heterologous single strand-binding protein or a single-stranded (ss) DNA that is complementary to the unwound strand. We show that TWINKLE, although a helicase, has an antagonistic activity of annealing two complementary ssDNAs that interferes with unwinding in the absence of gp2.5 or ssDNA trap. Furthermore, only ssDNA and not double-stranded (ds)DNA competitively inhibits the annealing activity, although both DNAs bind with high affinities. This implies that dsDNA binds to a site that is distinct from the ssDNA-binding site that promotes annealing. Fluorescence anisotropy competition binding experiments suggest that TWINKLE has more than one ssDNA-binding sites, and we speculate that a surface-exposed ssDNA-specific site is involved in catalyzing DNA annealing. We propose that the strand annealing activity of TWINKLE may play a role in recombination-mediated replication initiation found in the mitochondria of mammalian brain and heart or in replication fork regression during repair of damaged DNA replication forks.


Assuntos
DNA Helicases/química , DNA Mitocondrial/química , DNA de Cadeia Simples/química , Proteínas Mitocondriais/química , Sítios de Ligação , DNA Helicases/genética , DNA Helicases/metabolismo , Reparo do DNA/fisiologia , Replicação do DNA/fisiologia , DNA Mitocondrial/biossíntese , DNA Mitocondrial/genética , DNA de Cadeia Simples/genética , DNA de Cadeia Simples/metabolismo , Humanos , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Ligação Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Uridina Trifosfato/química , Uridina Trifosfato/metabolismo
2.
Photochem Photobiol ; 79(6): 506-9, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15291300

RESUMO

Antifungal activity is positively correlated to furanocoumarin content in extracts of the traditional phytomedicine northern prickly ash (Zanthoxylum americanum Mill. [Rutaceae]). The specificity of these furanocoumarins in inhibiting replication of DNA was investigated with reference to significant base composition differences between fungal and mammalian mitochondrial DNA. We developed a polymerase chain reaction-based assay to investigate whether (1) furanocoumarins inhibit DNA polymerization and (2) distinct furanocoumarins specifically inhibit DNA replication depending on base composition. Specific inhibition of DNA polymerization by 5-methoxypsoralen and psoralen through high-adenine and thymine (AT) (84.3%) and low-AT (51.9%) DNA, respectively, suggests that furanocoumarins inhibit replicative functions of genomes or of regions within the genome that differ in base composition. Greater overall inhibition of DNA polymerization by Z. americanum husk extracts than with single or mixed furanocoumarins suggests that inhibitory compounds in addition to the major furanocoumarins are present in Z. americanum.


Assuntos
Antifúngicos/farmacologia , Replicação do DNA/efeitos dos fármacos , DNA Mitocondrial/biossíntese , Furocumarinas/farmacologia , Medicina Tradicional , Metoxaleno/análogos & derivados , Extratos Vegetais/farmacologia , Rutaceae/química , 5-Metoxipsoraleno , Animais , Antifúngicos/isolamento & purificação , Composição de Bases , Replicação do DNA/efeitos da radiação , DNA Mitocondrial/genética , Furocumarinas/isolamento & purificação , Humanos , Metoxaleno/farmacologia , Fitoterapia , Extratos Vegetais/isolamento & purificação , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/crescimento & desenvolvimento , Saccharomyces cerevisiae/metabolismo , Raios Ultravioleta
3.
Antiviral Res ; 34(3): 131-6, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9191020

RESUMO

Carbovir (CBV) is a guanine nucleoside analog with potent in vitro anti-HIV activity. A prodrug of CBV is currently being evaluated in clinical trials as a potential agent for the treatment of AIDS. The ability of CBV to inhibit mitochondrial DNA synthesis in intact CEM cells was evaluated in the present study, because most of the currently available anti-HIV nucleoside analogs have significant toxicities that result from their inhibition of mitochondrial DNA synthesis. No delayed cytotoxicity was observed in CEM cells treated with 50 microM CBV for 4 weeks. In addition, CBV at concentrations as high as 1 mM did not cause a decline in mitochondrial DNA levels and only minimally increased the concentration of lactic acid in the medium. In contrast to these results with CBV, treatment of CEM cells with 0.5 microM 2',3'-dideoxycytidine resulted in delayed cytotoxicity, a decrease in mitochondrial DNA content and increases in lactic acid levels in the medium. These results indicated that treatment of CEM cells with CBV did not result in the inhibition of mitochondrial DNA synthesis and suggested that treatment of AIDS patients with CBV, or a prodrug of CBV, would not result in some of the toxicities seen with the other anti-HIV nucleoside analogs.


Assuntos
Fármacos Anti-HIV/toxicidade , Didesoxinucleosídeos/toxicidade , Mitocôndrias/efeitos dos fármacos , Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Síndrome da Imunodeficiência Adquirida/virologia , Linhagem Celular , DNA Mitocondrial/biossíntese , Avaliação Pré-Clínica de Medicamentos , Humanos , Ácido Láctico/metabolismo , Mitocôndrias/metabolismo , Pró-Fármacos/toxicidade , Zalcitabina/toxicidade
4.
Biochem Pharmacol ; 52(10): 1577-84, 1996 Nov 22.
Artigo em Inglês | MEDLINE | ID: mdl-8937473

RESUMO

A group of enantiomeric nucleoside analogues with beta-D or beta-L configuration, which represent potential candidates for the treatment of hepatitis B virus (HBV) infection, were incubated in human hepatoblastoma HepG2 cells at concentrations between 0.1 and 10 microM for 4-14 days. Then the effect on mitochondrial DNA (mtDNA) content, lactic acid production, lipid droplet formation, and mitochondrial morphology were evaluated. No effect on lactic acid production was detected in cells treated with beta-L-2',3'-dideoxy-3'-thiacytidine (3TC), beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine (beta-L-FTC), beta-D-2',3'-dideoxy-5-fluoro-3'-thiacytidine (beta-D-FTC), racemic cis 2',3'-dideoxy-5-fluoro-3'thiacytidine [(+/-)-FTC], and 2,4-diamino-7-(2,3-dideoxy-2-fluoro-beta-D-arabinofuranosyl) pyrrolo[2',3'-d]pyrimidine (T70178), whereas a slight increase was associated with beta-D-2-hydroxymethyl-5-(2,6-diaminopurin-9-yl)-1,3-dixolane++ + (beta-D-DAPD) and 4-amino-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d]pyrimi dine -5-thiocarboxamide (T70182) at 10 microM. A concentration-dependent increase in lactic acid production was observed in cells exposed to beta-D-2',3'-dideoxy-3'-thiacytidine [(+)-BCH-189], racemic cis 2',3'-dideoxy-3'-thiacytidine [(+/-)-BCH-189], beta-D-2',3'-dideoxy-5-fluorocytidine (beta-D-FddC), beta-L-2',3'-dideoxy-5-fluorocytidine (beta-L-FddC), beta-D-2-hydroxymethyl-5-(5-fluorocytosin-I-yl)-1,3,-dioxolane (beta-D-FDOC), 2,4-diamino-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) pyrrolo[2,3-d]pyrimidine (T70080), and 4-amino-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo [2,3-d]pyrimidine (T70179). Inhibition on mtDNA content was demonstrated to be concentration-dependent with (+)-BCH-189, beta-D-FddC, and T70080, whereas 3TC, (+/-)-BCH-189, beta-L-FTC, beta-D-FTC, (+/-)-FTC, beta-L-FddC, beta-D-DAPD, T70178, T70179, and T70182 had no effect. beta-D-FDOC resulted in a marked inhibition of mtDNA synthesis at 10 microM but not at lower concentrations. Cells treated with 3TC, (+/-)-BCH-189, beta-L-FTC, beta-D-FTC, (+/-)-FTC, beta-L-FddC, beta-D-DAPD, T70178, T70179, and T70182 did not show morphological changes compared with the control. In contrast, increased cytoplasmic lipid droplets associated with a loss of cristae in mitochondria were detected in cells treated with either beta-D-FDOC, beta-D-FddC, or T70080, (+)-BCH-189 treatment resulted in loss of cristae in mitochondria. In summary, 3TC, beta-L-FTC, beta-D-FTC, (+/-)-FTC, beta-D-DAPD, T70178, and T70182 exhibited a relatively safe profile, supporting their further development.


Assuntos
Mitocôndrias Hepáticas/efeitos dos fármacos , Nucleosídeos/toxicidade , Antivirais/química , Antivirais/farmacologia , Antivirais/toxicidade , Divisão Celular/efeitos dos fármacos , Linhagem Celular , DNA Mitocondrial/biossíntese , Avaliação Pré-Clínica de Medicamentos , Hepatite B/tratamento farmacológico , Humanos , Ácido Láctico/biossíntese , Microscopia Eletrônica , Mitocôndrias Hepáticas/metabolismo , Mitocôndrias Hepáticas/ultraestrutura , Estrutura Molecular , Nucleosídeos/química , Nucleosídeos/farmacologia , Estereoisomerismo
5.
Arch Inst Pasteur Tunis ; 73(1-2): 13-6, 1996.
Artigo em Francês | MEDLINE | ID: mdl-9412440

RESUMO

Pentobarbital, an inhibitor of respiratory chain at site II stimulates mitochondrial ADP ribosylation of glia cells. Results show an in cause of approximatively 30% of the ADP ribosyl transferase activity under pentobarbital treatment. ADP ribosyl transferase modifies two major mitochondrial proteins at molecular weight 50 and 80 KDa. The pentobarbital has been reported to induce neobiogenesis of mitochondria with enhancement of mitochondrial DNA synthesis. The stimulation of ADP ribosyl transferase activity under respiratory chain inhibition suggest the implication of this effect on neobiogenesis of mitochondria.


Assuntos
Difosfato de Adenosina/metabolismo , DNA Mitocondrial/biossíntese , DNA Mitocondrial/efeitos dos fármacos , Hipnóticos e Sedativos/farmacologia , Mitocôndrias/efeitos dos fármacos , Neuroglia/efeitos dos fármacos , Pentobarbital/farmacologia , Animais , Avaliação Pré-Clínica de Medicamentos , Glicosilação , Peso Molecular , Ratos , Ribose/metabolismo
6.
Curr Genet ; 14(2): 163-70, 1988 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2846190

RESUMO

Broad bean (Vicia faba) mitochondrial DNA (mtDNA) includes three circular plasmids: mt-plasmid 1 (1,704 ntp), mt-plasmid 2 (1,695 ntp) and mt-plasmid 3 (1,476 ntp). Partially replicated circular forms of these mt-plasmids have been observed in electron microscope preparations. Restriction enzymes that cleave either mt-plasmid 2 (but not mt-plasmids 1 and 3) or mt-plasmid 3 (but not mt-plasmids 1 and 2) were used to generate linear forms of partially replicated mt-plasmid 2 and mt-plasmid 3 molecules. Analyses of these linearized replicative intermediates, observed by electron microscopy, indicated that in both mt-plasmid 2 and mt-plasmid 3 replication originates at a specific location and proceeds in the same, single direction around the molecules. The replication origins of mt-plasmid 2 and mt-plasmid 3 map close to sequences that can fold into hairpin structures.


Assuntos
Replicação do DNA , DNA Circular/biossíntese , DNA Mitocondrial/biossíntese , Plasmídeos , Enzimas de Restrição do DNA , DNA Circular/genética , DNA Circular/ultraestrutura , DNA Mitocondrial/genética , DNA Mitocondrial/ultraestrutura , Desoxirribonucleases de Sítio Específico do Tipo II , Fabaceae , Microscopia Eletrônica , Plantas Medicinais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA